Unitedhealth Group Inc (NYSE:UNH) shares traded -1.32% lower at $418.64 on Wall Street last session.
UNH stock price is now -16.68% away from the 50-day moving average and -23.59% away from the 200-day moving average. The market capitalization of the company currently stands at $382.94B.
With the price target maintained at $490, HSBC Securities recently Downgraded its rating from Buy to Hold for Unitedhealth Group Inc (NYSE: UNH). , while ‘HSBC Securities’ rates the stock as ‘Buy’
In other news, FLYNN TIMOTHY PATRICK, Director bought 1,000 shares of the company’s stock on Jan 17 ’25. The stock was bought for $511,575 at an average price of $511.57. Upon completion of the transaction, the Director now directly owns 4,500 shares in the company, valued at $1.88 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 11 ’24, EVP & Chief People Officer McSweeney Erin sold 701 shares of the business’s stock. A total of $438,987 was realized by selling the stock at an average price of $626.23. This leaves the insider owning 7,105 shares of the company worth $2.97 million. A total of 0.21% of the company’s stock is owned by insiders.
During the past 12 months, Unitedhealth Group Inc has had a low of $417.12 and a high of $630.73. According to the stock market information, the enterprise value for the company is $435649511424, which is based on a 17.50 price-to-earnings ratio, a 2.04 price-to-earnings-growth ratio, and a beta of 0.59. The fifty day moving average price for UNH is $502.4724 and a two-hundred day moving average price translates $547.8879 for the stock.
The latest earnings results from Unitedhealth Group Inc (NYSE: UNH) was released for 2025-03-31. The net profit margin was 5.39% and return on equity was 15.88% for UNH. The company reported revenue of $100.81 billion for the quarter, compared to $94.43 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 6.76 percent.
